Walvax | Briefing, News, Analysis, Research, Data

Walvax

Yunnan Watson Biotechnology Co., Ltd. is a modern biopharmaceutical company specializing in the research and manufacture

Yunnan Watson Biotechnology Co., Ltd. is a modern biopharmaceutical company specializing in the research and manufacture The company was listed on the GEM Board of China Shenzhen Stock Exchange in November 2010 (stock abbreviation: Watson Bio; stock code: 300142).

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Jan 16, 2001

HQ location

Yunnan, China

Legal name

Walvax Biotechnology Co., Ltd.

Website

http://www.walvax.com/

ir@walvax.com

Employees

1001-5000

All
News
Analysis
Research

Briefing May 17, 2022 03:10 PM · Consumer Discretionary | Consumer Staples

SARFT Launches Online drama distribution license

Briefing Apr 19, 2022 09:44 AM · Healthcare | Real Estate | Industrials

The logistics sector opened lower, and Changlian shares fell by the limit

In-depth

Healthcare

EqualOcean Sector Quarterly Report - Healthcare Sectors

To help worldwide investors keep track of what is happening in each industry or sector and the related hot spots, we launched the EqualOcean Sector Quarterly Report series, which gathers notable information and statistics in each quarter.

Apr 07, 2022 01:44 PM

Briefing Feb 14, 2022 05:00 PM · Healthcare | Real Estate | Financials

Optical cable: it is proposed to set up Jiangsu Tong Optoelectronics Technology, which is mainly engaged in raw material trade

Briefing Jan 28, 2022 10:19 PM · Healthcare | Consumer Staples

Watson biology: the net profit in 2021 is expected to decrease by 54% - 64% year-on-year

Research

Financials, Technology, Healthcare

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Research

Healthcare, Consumer Staples, Technology

WIA2020 | Rising Tech Stars 2020: Global & China's 100

Dec 09, 2020 09:57 AM

Research

Healthcare

WIA2020 | Next 50 in Global Tech: Healthcare

Dec 09, 2020 09:39 AM

Research

Healthcare, Technology, Consumer Discretionary

Tech for Global, Globalization Footprints of the Established and the New

May 29, 2020 08:30 PM

Briefing Jan 28, 2022 08:49 PM · Technology | Healthcare

Watson biology: 13 valent pneumococcal polysaccharide conjugate vaccine has been licensed in Morocco

Briefing Jan 10, 2022 09:19 AM · Healthcare | Financials | Technology

22 stocks were significantly large-scale, * ST Daji 5-day volume ratio reached 127 times

Briefing Dec 29, 2021 09:39 AM · Consumer Staples | Healthcare

The pharmaceutical and biological sector has been heavily sold off by the main funds in the past three days

Briefing Dec 28, 2021 06:49 PM · Consumer Staples | Technology | Financials

Huarong Holdings: terminate the purchase of 100% equity of Xinchao biology and resume trading tomorrow

Healthcare, Consumer Staples

RLX Technology’s Net Profit Fell by 41.1% YoY

Government regulations and COVID-19 were restricting RLX Technology’s development.

May 20, 2022 03:03 PM

Healthcare

The Subsidiaries of Hengrui Pharma Gained Clinical Trial Approval Again

It will further complete the pipeline drug profiles of the pharma giant, Hengrui Pharma.

May 19, 2022 12:28 PM

Briefing Dec 12, 2021 05:48 PM · Healthcare

Watson biology: Yuxi Watson plans to invest in the production and capacity expansion project of polysaccharide conjugate vaccine, with a total investment of 695 million yuan

Briefing Dec 10, 2021 08:19 PM · Technology | Automotive | Healthcare

Chongqing Road and Bridge: the shareholder Shanghai Linjun plans to increase its shareholding by 1% to 7%

Briefing Nov 10, 2021 01:38 PM · Technology | Healthcare

Shandong's largest hydrogen fuel cell hydrogen supply project completed

Healthcare

National Insulin Procurement is Implemented in Shandong Province, China

Chinese National Centralized Drug Procurement program is launched in 2019, aiming to lower drug prices and reduce drug expenditures by volume-based durg procurement.

May 19, 2022 10:56 AM

Healthcare

Chinese Biotech Startup Laekna Therapeutics Nets USD 61 Million in Series D Round

As a clinical-stage biotech company, Laekna has attracted several top investment institutions in the healthcare field.

May 18, 2022 08:36 PM

Briefing Sep 02, 2021 02:06 PM · Healthcare

Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%

Briefing Sep 02, 2021 10:22 AM · Healthcare | Financials

The biological vaccine sector weakened, and Watson biology fell more than 6%

Briefing Aug 06, 2021 01:08 PM · Healthcare | Financials | Technology

Will Huawei's server business be packaged for sale? Huawei insiders: business is affected but will not give up

Briefing Jul 29, 2021 10:01 AM

Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%

EqualOcean Analysis

EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.

Address

Beijing 9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China
Shanghai 2707-2708, AI Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China

New York Suite 2967, 29th Floor, 4 World Trade 150 Greenwich St, New York, NY 10006

About